INVEX THERAPEUTICS
Who is INVEX THERAPEUTICS?
Invex Therapeutics (ASX: IXC) is a biopharmaceutical company focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of neurological conditions derived from or involving raised intracranial pressure, such as Idiopathic Intracranial Hypertension (IIH), acute strok...See more
Industry & Specialities
Others
Countries of Operation
Australia
Headquarters:
Australia
Company Type:
MNC / Large Enterprise
Company size:
1-10 Employees
Year Founded:
2019 (7 years)
Address:
38 ROWLAND STREET; LEVEL 1; SUBIACO, WA 6008, AU
Employees by Department
- The Rest (1)
- Total (1)
Key Decision Makers
No Records Found
Employees by Seniority
C-level
0employees
Senior
0employees
Non-managers
0employees
Financials
LOW
spending power
Funding Status
Publicly listed on stock exchange
Associated Legal Entities
0 entities
Discover More Companies
Lookalike companies
Featured Lists
- SMEs in Singapore
- MNCs / Large Enterprises in Singapore
Frequently Asked Questions (FAQ)
- How long has INVEX THERAPEUTICS been operating for?
- What is the funding status of INVEX THERAPEUTICS?
- Where is INVEX THERAPEUTICS's headquarter?
- What INVEX THERAPEUTICS's spending power?
- Does INVEX THERAPEUTICS have a presence in the domain it operates in?